BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31144375)

  • 1. Wnt7a, frequently silenced by CpG methylation, inhibits tumor growth and metastasis via suppressing epithelial-mesenchymal transition in gastric cancer.
    Liu Y; Qiao Y; Zhang H; Li W; Zheng J
    J Cell Biochem; 2019 Oct; 120(10):18142-18151. PubMed ID: 31144375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
    Zhao W; Jia L; Kuai X; Tang Q; Huang X; Yang T; Qiu Z; Zhu J; Huang J; Huang W; Feng Z
    Cancer Med; 2019 Mar; 8(3):1135-1147. PubMed ID: 30632714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.
    Huang J; He Y; Mcleod HL; Xie Y; Xiao D; Hu H; Chen P; Shen L; Zeng S; Yin X; Ge J; Li L; Tang L; Ma J; Chen Z
    BMC Cancer; 2017 Dec; 17(1):886. PubMed ID: 29273006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
    Liu L; Tian YC; Mao G; Zhang YG; Han L
    Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TYRO3 facilitates cell growth and metastasis via activation of the Wnt/β-catenin signaling pathway in human gastric cancer cells.
    Chen D; Liu Q; Cao G; Zhang W
    Aging (Albany NY); 2020 Feb; 12(3):2261-2274. PubMed ID: 32018224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p.
    Huang X; Zhu H; Gao Z; Li J; Zhuang J; Dong Y; Shen B; Li M; Zhou H; Guo H; Huang R; Yan J
    J Biol Chem; 2018 May; 293(18):6693-6706. PubMed ID: 29549123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
    Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway.
    Tian S; Peng P; Li J; Deng H; Zhan N; Zeng Z; Dong W
    Aging (Albany NY); 2020 Feb; 12(4):3574-3593. PubMed ID: 32091407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt7a predicts poor prognosis, and contributes to growth and metastasis in tongue squamous cell carcinoma.
    Jia B; Qiu X; Chu H; Sun X; Xu S; Zhao X; Zhao J
    Oncol Rep; 2019 Mar; 41(3):1749-1758. PubMed ID: 30747225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma.
    Wu DJ; Jiang YS; He RZ; Tao LY; Yang MW; Fu XL; Yang JY; Zhu K
    Sci Rep; 2018 Oct; 8(1):15792. PubMed ID: 30361522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.
    Zhang Z; Dai DQ
    World J Gastroenterol; 2019 Mar; 25(10):1224-1237. PubMed ID: 30886505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BARX2 expression is downregulated by CpG island hypermethylation and is associated with suppressed cell proliferation and invasion of gastric cancer cells.
    Ma J; Xia LL; Yao XQ; Zheng SM; Li S; Xu LS; Sha WH; Li ZS
    Oncol Rep; 2020 Jun; 43(6):1805-1818. PubMed ID: 32236603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
    Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer.
    Li Z; Lei H; Luo M; Wang Y; Dong L; Ma Y; Liu C; Song W; Wang F; Zhang J; Shen J; Yu J
    Gastric Cancer; 2015 Jan; 18(1):43-54. PubMed ID: 24481854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
    BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
    Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
    J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer.
    Chen Y; Liu J; Wang W; Xiang L; Wang J; Liu S; Zhou H; Guo Z
    Oncol Rep; 2018 Apr; 39(4):1693-1701. PubMed ID: 29484423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses proliferation and epithelial mesenchymal transformation of gastric cancer cells.
    Wang JB; Jin Y; Wu P; Liu Y; Zhao WJ; Chen JF; De W; Yang F
    Oncol Rep; 2019 Feb; 41(2):1007-1018. PubMed ID: 30431129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
    Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
    Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.